Injectable Nanomedicines Market to Witness Exponential Growth Driven by Rising Cancer Treatments
The Injectable Nanomedicines Market is forecast to achieve remarkable growth, rising from USD 20.4 billion in 2025 to USD 64.6 billion by 2035, at a robust compound annual growth rate (CAGR) of 12.2%. The market’s momentum is driven by rising global demand for targeted drug delivery systems, growing cancer prevalence, and continuous advancements in nanotechnology-based therapeutics....
0 Kommentare 0 Geteilt 25 Ansichten 0 Bewertungen